ObsEva (NASDAQ:OBSV) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a research report sent to investors on Thursday. The firm issued a hold rating on the stock.

ObsEva Trading Down 15.5 %

OBSV opened at $0.10 on Thursday. The company’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.04. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The company has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.